Professor of Oncology, Institute of Infection and Immunity
St George's, University of London, UK
Professor Angus Dalgleish studied medicine at University College London where he obtained an MBBS and a BSc in Anatomy. He is a Fellow of The Royal College of Physicians of the UK and Australia, Royal College of Pathologists and The Academy of Medical Scientists. Currently he focussed on HIV pathogenesis and development of therapeutic vaccines. He is a co-founder of Onyvax, a company set up in 1998 to make novel vaccines for common solid tumours, where he is currently Research Director. He is the author or co-author of peer reviewed scientific papers and over 70 chapters in medical books. He is the co-editor of five medical books. He has been on numerous grant committees and is currently on the European Commission Cancer Board.
Prof. Angus Dalgleish research interests includes HIV pathogenesis, Virus induced cancers and development of therapeutic vaccines.